Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for IOBCF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for IOBCF and 80,000+ other tickers.
See exactly how IOBCF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IOBCF and 80,000+ other tickers.
Ion Beam Applications S.A. (IBA) is a company specializing in the design, manufacturing, and ongoing support of sophisticated medical equipment and software solutions primarily focused on treating cancer. Its operations span Belgium, the United States, and various international markets. The company's activities are broadly organized into two main divisions: 1. Proton Therapy and Other Accelerators: This segment is responsible for the engineering, construction, and maintenance of both medical and industrial particle accelerators, including complete proton therapy systems. It also delivers…
BlackRock Inc. purchased a new stake in shares of Ion Beam Applications SA (OTCMKTS:IOBCF) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 4,425,516 shares of the company's stock, valued at approximately $488,621,000. Other institutional investors and hedge funds have
Deutsche Bank AG acquired a new position in Ion Beam Applications SA (OTCMKTS:IOBCF) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 91,839 shares of the company's stock, valued at approximately $10,140,000. Other hedge funds have also recently made changes
Ion Beam Applications SA (OTCMKTS:IOBCF - Get Free Report) was up 5.3% during trading on Thursday. The stock traded as high as $15.80 and last traded at $15.80. Approximately 100 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 613 shares. The stock had previously closed at
Ion Beam Applications SA (IOBCF) Q4 2025 Earnings Call Transcript
Ion Beam Applications SA (OTCPK:IOBCF) Q3 2025 Earnings Call November 20, 2025 10:30 AM EST Company Participants Catherine Vandenborre - Chief Financial Officer & Corporate Lead Thomas Pevenage Olivier Legrain - CEO, MD & Executive Director Conference Call Participants David Vagman - ING Groep N.V., Research Division Laura Roba - Banque Degroof Petercam S.A.